Literature DB >> 23707380

In human pseudouridine synthase 1 (hPus1), a C-terminal helical insert blocks tRNA from binding in the same orientation as in the Pus1 bacterial homologue TruA, consistent with their different target selectivities.

Nadine Czudnochowski1, Amy Liya Wang, Janet Finer-Moore, Robert M Stroud.   

Abstract

Human pseudouridine (Ψ) synthase Pus1 (hPus1) modifies specific uridine residues in several non-coding RNAs: tRNA, U2 spliceosomal RNA, and steroid receptor activator RNA. We report three structures of the catalytic core domain of hPus1 from two crystal forms, at 1.8Å resolution. The structures are the first of a mammalian Ψ synthase from the set of five Ψ synthase families common to all kingdoms of life. hPus1 adopts a fold similar to bacterial Ψ synthases, with a central antiparallel β-sheet flanked by helices and loops. A flexible hinge at the base of the sheet allows the enzyme to open and close around an electropositive active-site cleft. In one crystal form, a molecule of Mes [2-(N-morpholino)ethane sulfonic acid] mimics the target uridine of an RNA substrate. A positively charged electrostatic surface extends from the active site towards the N-terminus of the catalytic domain, suggesting an extensive binding site specific for target RNAs. Two α-helices C-terminal to the core domain, but unique to hPus1, extend along the back and top of the central β-sheet and form the walls of the RNA binding surface. Docking of tRNA to hPus1 in a productive orientation requires only minor conformational changes to enzyme and tRNA. The docked tRNA is bound by the electropositive surface of the protein employing a completely different binding mode than that seen for the tRNA complex of the Escherichia coli homologue TruA.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2-(N-morpholino)ethane sulfonic acid; FAM; MLASA; Mes; PDB; PEG; Protein Data Bank; RNA-modifying enzyme; SRA; X-ray crystallography; fluorescein amidite; hPus1; human pseudouridine synthase 1; isomerase; mitochondrial myopathy and sideroblastic anemia; polyethylene glycol; pseudouridine; steroid receptor RNA activator; tRNA

Mesh:

Substances:

Year:  2013        PMID: 23707380      PMCID: PMC3900414          DOI: 10.1016/j.jmb.2013.05.014

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  45 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Crystal structure of pseudouridine synthase RluA: indirect sequence readout through protein-induced RNA structure.

Authors:  Charmaine Hoang; Junjun Chen; Caroline A Vizthum; Jason M Kandel; Christopher S Hamilton; Eugene G Mueller; Adrian R Ferré-D'Amaré
Journal:  Mol Cell       Date:  2006-11-17       Impact factor: 17.970

3.  Crystal structure of human Pus10, a novel pseudouridine synthase.

Authors:  Clare J McCleverty; Michael Hornsby; Glen Spraggon; Andreas Kreusch
Journal:  J Mol Biol       Date:  2007-08-29       Impact factor: 5.469

4.  Modifications of U2 snRNA are required for snRNP assembly and pre-mRNA splicing.

Authors:  Y T Yu; M D Shu; J A Steitz
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

5.  Cloning and characterization of a mammalian pseudouridine synthase.

Authors:  J Chen; J R Patton
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

6.  Pseudouridine mapping in the Saccharomyces cerevisiae spliceosomal U small nuclear RNAs (snRNAs) reveals that pseudouridine synthase pus1p exhibits a dual substrate specificity for U2 snRNA and tRNA.

Authors:  S Massenet; Y Motorin; D L Lafontaine; E C Hurt; H Grosjean; C Branlant
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

7.  Crystal structure of an RluF-RNA complex: a base-pair rearrangement is the key to selectivity of RluF for U2604 of the ribosome.

Authors:  Akram Alian; Andrew DeGiovanni; Sarah L Griner; Janet S Finer-Moore; Robert M Stroud
Journal:  J Mol Biol       Date:  2009-03-17       Impact factor: 5.469

Review 8.  Decoding the genome: a modified view.

Authors:  Paul F Agris
Journal:  Nucleic Acids Res       Date:  2004-01-09       Impact factor: 16.971

Review 9.  Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer.

Authors:  Etienne Leygue
Journal:  Nucl Recept Signal       Date:  2007-08-03

10.  RAPIDO: a web server for the alignment of protein structures in the presence of conformational changes.

Authors:  Roberto Mosca; Thomas R Schneider
Journal:  Nucleic Acids Res       Date:  2008-05-06       Impact factor: 16.971

View more
  15 in total

1.  A pseudouridine residue in the spliceosome core is part of the filamentous growth program in yeast.

Authors:  Anindita Basak; Charles C Query
Journal:  Cell Rep       Date:  2014-08-07       Impact factor: 9.423

Review 2.  The Evolution of Substrate Specificity by tRNA Modification Enzymes.

Authors:  Katherine M McKenney; Mary Anne T Rubio; Juan D Alfonzo
Journal:  Enzymes       Date:  2017-04-26

Review 3.  Pseudouridine: still mysterious, but never a fake (uridine)!

Authors:  Felix Spenkuch; Yuri Motorin; Mark Helm
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

Review 4.  Pseudouridines in RNAs: switching atoms means shifting paradigms.

Authors:  Ting-Yu Lin; Rahul Mehta; Sebastian Glatt
Journal:  FEBS Lett       Date:  2021-09-13       Impact factor: 3.864

Review 5.  Regulation and Function of RNA Pseudouridylation in Human Cells.

Authors:  Erin K Borchardt; Nicole M Martinez; Wendy V Gilbert
Journal:  Annu Rev Genet       Date:  2020-09-01       Impact factor: 16.830

6.  Dye label interference with RNA modification reveals 5-fluorouridine as non-covalent inhibitor.

Authors:  Felix Spenkuch; Gerald Hinze; Stefanie Kellner; Christoph Kreutz; Ronald Micura; Thomas Basché; Mark Helm
Journal:  Nucleic Acids Res       Date:  2014-10-09       Impact factor: 16.971

7.  Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing.

Authors:  Nicole M Martinez; Amanda Su; Margaret C Burns; Julia K Nussbacher; Cassandra Schaening; Shashank Sathe; Gene W Yeo; Wendy V Gilbert
Journal:  Mol Cell       Date:  2022-01-19       Impact factor: 17.970

8.  Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations.

Authors:  Michelangelo Cao; Marta Donà; M Lucia Valentino; Lucia Valentino; Claudio Semplicini; Alessandra Maresca; Matteo Cassina; Alessandra Torraco; Eva Galletta; Valeria Manfioli; Gianni Sorarù; Valerio Carelli; Roberto Stramare; Enrico Bertini; Rosalba Carrozzo; Leonardo Salviati; Elena Pegoraro
Journal:  Neurogenetics       Date:  2015-11-10       Impact factor: 2.660

Review 9.  Long Non-Coding RNA Epigenetics.

Authors:  Marek Kazimierczyk; Jan Wrzesinski
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

10.  Steroid receptor RNA activator (SRA) modification by the human pseudouridine synthase 1 (hPus1p): RNA binding, activity, and atomic model.

Authors:  Tiphaine Huet; François-Alexandre Miannay; Jeffrey R Patton; Stéphane Thore
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.